11 – 20 of 469
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI : The ProScreen Randomized Trial
- Contribution to journal › Article
-
Mark
Eight Misconceptions about Prostate-Specific Antigen
- Contribution to journal › Article
-
Mark
Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death-Results from the Norwegian Prostate Cancer Consortium
- Contribution to journal › Article
-
Mark
A PSA SNP associates with cellular function and clinical outcome in men with prostate cancer
- Contribution to journal › Article
- 2023
-
Mark
Screening for prostate cancer : evidence, ongoing trials, policies and knowledge gaps
- Contribution to journal › Scientific review
-
Mark
Acoustic enrichment of heterogenous circulating tumor cells and clusters from patients with metastatic prostate cancer
(2023)
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves cross-ancestry prediction
(2023)
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Acoustophoresis enrichment of tumor cell clusters in blood of patients with metastatic prostate cancer
(2023) The 27th International Conference on Miniaturized Systems for Chemistry and Life Sciences (µTAS 2023)
- Contribution to conference › Abstract
-
Mark
Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality : 24-Year Follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial
- Contribution to journal › Article
-
Mark
Addition of a Genetic Risk Score for Identification of Men with a Low Prostate-specific Antigen Level in Midlife at Risk of Developing Lethal Prostate Cancer
- Contribution to journal › Letter
